Practical, step-by-step guides for anyone starting or managing GLP-1 treatment. Learn how to begin safely, what to expect week by week, and how to get the most from your medication with confidence.
Patient Guides
A new study from Children's Hospital Los Angeles found that GLP-1 medications may improve weight loss outcomes in adolescents who have already had bariatric surgery. The findings raise important questions about combination approaches to treating severe obesity in teens. Here's a practical look at what the research means and what families should ask their doctors.
Mounjaro (tirzepatide) has crossed 1.5 million prescriptions, with notable growth among younger patients including teens. This surge raises important questions about access, safety, cost, and what you should ask your doctor before starting treatment.
GLP-1 medications like semaglutide and tirzepatide are known for weight loss, but they also quietly reshape daily life at home. From smaller portion habits to rethinking your kitchen, the lifestyle shifts are real and worth preparing for. Here's what to expect and how to set yourself up for success.
GLP-1 medications like semaglutide and tirzepatide raise a lot of questions for first-time patients. This article answers the most common ones directly, covering safety, eligibility, side effects, cost, and how to find the right provider.
Super Junior's Shindong made headlines after losing 37 kg in five months on Wegovy and then stopping the medication. His story raises real questions about semaglutide results, the "obesity gene," and what happens when you discontinue GLP-1 treatment.
Emerging research suggests oral GLP-1 medications may reduce food cravings by acting directly on the brain's reward and appetite circuits. This could reshape how patients and providers think about pill-based alternatives to injectable GLP-1 drugs. Here's what the science shows and what it means for you.
Millions of people want the appetite-suppressing, blood sugar-stabilizing benefits of Ozempic without the weekly injection. This article breaks down what needle-free alternatives actually exist, what the science supports, and how to think through your options with a doctor.
Australian health regulators have issued a warning about a rare but serious eye disorder that may be linked to GLP-1 medications like Ozempic and Wegovy. While the risk appears low, patients on these drugs should know the warning signs and what to discuss with their doctor. This guide breaks down what the science says, who may be at higher risk, and practical steps to protect your vision.
